Close
Help
Need Help?



Tobacco, Genetic Susceptibility and Lung Cancer

Submit a Paper


LA Press Analytics


53 Article Views

Publication Date: 28 Jan 2010

Journal: Tobacco Use Insights 2010:3 1-15


journal

53 Article Views

1,783,297 LA Press Article Views

More Statistics

Abstract Exposure to tobacco smoke is an established risk factor for lung cancer, although a possible role for genetic susceptibility in the development of lung cancer has been inferred from familial clustering of the disease and segregation analysis. Findings of familial aggregation and statistical evidence for a major susceptibility gene have led to the search for high penetrant, rare, single genes and low penetrant, high frequency susceptibility genes for lung cancer. The relatively small number of linkage studies conducted to date, have identified potential lung cancer susceptibility loci on chromosomes 6q, 12p, and 19q. A variety of studies have examined single nucleotide polymorphisms of several low penetrant, high frequency genes encoding for enzymes involved in the metabolism of carcinogens and DNA damage repair, as likely candidate susceptibility genes. These studies have produced somewhat conflicting findings and, when significant, only modest associations have been reported. Relatively few studies have looked for potential gene-environment interactions, explored associations between two or more genetic polymorphisms or evaluated interactions between genetic polymorphisms and endogenous risk factors. Few large scale genome wide association studies conducted recently have provided evidence that common variation on chromosome 15q25.1, 5p15.33 and 6p21.33 influences lung cancer risk and cancer types with strong environmental risk factors. It is hoped that newer research strategies, selecting candidate genes within pathways and genotype at multiple markers within a gene, employing new technologies, may allow complete coverage of the variation within candidate genes in multiple pathways and to unravel the genetic susceptibility to lung cancer. This knowledge could, in turn, be used to identify persons at risk, to individualize treatments such as chemoprevention, to personalize harms of smoking and to motivate cessation.


Post a Comment

x close

Discussion Add A Comment
No comments yet...Be the first to comment.


share on

Our Service Promise

  • Prompt Publication (Average 3 Weeks)
  • Fair & Constructive Peer Review
  • Professional Author Service
  • High Visibility
  • High Readership
  • What Our Authors Say

Quick Links

Follow Us We make it easy to find new research papers. RSS Feeds Email Alerts Twitter

BROWSE CATEGORIES
Our Testimonials
This is my second publication in Int J Tryptophan Res and my experience on this occasion was as great and enjoyable as with my first paper immediately preceding this one.  I commend the Editors and the Editorial Staff of this new and exciting journal for their professionalism and dedication to science and scientific publishing.
Dr Abdulla Badawy, Professor of Clinical Biochemistry, University of Wales Institute Cardiff (UWIC), Wales, UK () What our authors say